$BKHA

Black Hawk Acquisition Corp

1
1
0

No SEC Form 4 filings for $BKHA in the last 30 days.

See all $BKHA insider activity →
Med

Black Hawk Acquisition Corp (BKHA): Entry into a Material Definitive Agreement

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a

Black Hawk Acquisition Corp (BKHA): Other Events

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i

Black Hawk Acquisition Corp (BKHA): Entry into a Material Definitive Agreement

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the

BKHA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BKHA (Black Hawk Acquisition Corp). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent BKHA coverage spans financial news and corporate actions.

What's driving BKHA

  • The agreements lock in financing and a backstop for up to ~2.1 M shares, reducing dilution risk and providing cash support, which could be viewed as a positive catalyst for the SPAC’s eventual de‑SPAC transaction.

    SEC EDGAR 8-K · Sep 24, 2026

  • The extension payment is a routine corporate filing that marginally improves the SPAC's timeline but does not change valuation.

    SEC EDGAR 8-K · Sep 22, 2026

  • The note creates a new financing obligation and potential dilution if converted, but the amount is modest for a SPAC.

    SEC EDGAR 8-K · Aug 26, 2026

  • The filings reveal a proposed merger with Vesicor Therapeutics, extension payments to trust, and insider ownership disclosures, suggesting strategic corporate developments.

    Stock Titan · May 1, 2026

  • Black Hawk Acquisition Corporation (BKHA) is a recently founded blank check company with limited trading history. The article highlights its key financial metrics and technical indicators, but due to its recent IPO status, trading activity and liquidity are limited. Overall, BKHA's stock shows low relevance for short-term trading but may be of interest for long-term investors considering its potential for future mergers or acquisitions.

    TradingView · Mar 5, 2026

AlphAI scores every news story that mentions BKHA with an AI model for sentiment and relevance, and aggregates insider trades from Black Hawk Acquisition Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BKHA

Score
$BKHAMed

Black Hawk Acquisition Corp (BKHA): Entry into a Material Definitive Agreement

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a

$BKHALow

Black Hawk Acquisition Corp (BKHA): Other Events

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i

$BKHALow

Black Hawk Acquisition Corp (BKHA): Entry into a Material Definitive Agreement

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the

$BKHALow

BKHA SEC Filings - Black Hawk Acquisition Corp 10-K, 10-Q, 8-K Forms

This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.

$BKHALow

BKHA Stock Price and Chart — NASDAQ:BKHA

This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.

$BKHAMed

Black Hawk Acquisition Announces Sponsor-Backed Convertible Note Financing

Black Hawk Acquisition Corporation (BKHA) has announced a sponsor-backed convertible note financing of up to $300,000 from Black Hawk Management LLC to cover working capital needs. The note bears 10% annual interest and matures upon the initial business combination or liquidation, with the sponsor having the option to receive cash repayment or convert the note into equity at $1.00 per share in a DeSPAC transaction. This flexible financing structure supports the SPAC's deal execution while aligning the sponsor's incentives with the combined company's future performance.

Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles

DANVILLE, Calif., April 28, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corp. ( Nasdaq: BKHAU, BKHA, BKHAR ) , a special purpose acquisition company, ( "Black Hawk" ) announced the signing of a Business Combination Agreement ( "BCA" ) on April 26, 2025, with Vesicor Therapeutics, Inc. ( ...

Related tickers